StarFill — JETEMA ZEEP HA Filler with Lidocaine

StarFill is JETEMA’s HA dermal filler — 24 mg/mL cross-linked HA + 0.3% lidocaine using patented ZEEP (Zero Endotoxin and BDDE Entire Process) technology. Endotoxin under 0.1 EU/mL with BDDE residue undetectable. Manufactured by the same Korean biopharmaceutical company behind the E.P.T.Q. range. Engineered for mid-to-deep dermal placement.

StarFill 24mg/ml Dermal Filler with Lidocaine is manufactured by JETEMA Co. Ltd., a South Korea-based medical device and pharmaceutical company established in 1994. The product is part of the StarFill dermal filler range, which is distributed across multiple international markets. Regulatory status: KFDA registered · CE marked · GMP certified.

StarFill 24mg/ml Dermal Filler with Lidocaine contains 24 mg/mL of cross-linked hyaluronic acid plus 0.3% (3 mg/mL) premixed lidocaine for injection comfort. The hyaluronic acid is non-animal, produced by bacterial fermentation and cross-linked using JETEMA Co. Ltd.’s ZEEP (Zero Endotoxin and BDDE Entire Process) Technology technology. Phosphate-buffered saline at near-physiological pH carries the gel.

Per JETEMA Co. Ltd.’s clinical data, StarFill 24mg/ml Dermal Filler with Lidocaine delivers 9-18 months of correction depending on placement and patient factors. Duration depends on injection depth, dose, anatomical site, patient metabolism, and facial movement intensity. Mid to deep dermis placement typically delivers the longer end of the duration range.

StarFill 24mg/ml Dermal Filler with Lidocaine is engineered for mid to deep dermis placement. The standard recommended needle is 27G, supplied in the syringe blister pack. Some practitioners prefer a blunt-tip cannula of equivalent gauge for safer placement in highly vascular zones, particularly for deeper subcutaneous work.

StarFill 24mg/ml Dermal Filler with Lidocaine regulatory status: KFDA registered · CE marked · GMP certified. The product’s KFDA registration in South Korea is the primary regulatory baseline. CE marking and other international approvals enable distribution in the EU and other regulated markets. US FDA status varies — buyers in regulated jurisdictions should verify approval scope before importation and clinical use.

Store StarFill 24mg/ml Dermal Filler with Lidocaine between 2 °C and 25 °C in original packaging, away from direct sunlight. Do not freeze — freezing damages the HA gel structure. Shelf life is typically 24 months from the manufacturing date printed on the box when unopened. Once a syringe is opened, contents must be used immediately. Partial syringes cannot be retained for later use due to sterility risk.

No. StarFill 24mg/ml Dermal Filler with Lidocaine uses non-animal hyaluronic acid produced by bacterial fermentation — the standard manufacturing approach for modern HA dermal fillers. The product contains no animal proteins or by-products, making it suitable for patients who avoid animal-derived medical products. The product is contraindicated in patients with severe allergies to gram-positive bacterial proteins (used in HA fermentation).

Yes — layered protocols combining different fillers are standard aesthetic practice. StarFill 24mg/ml Dermal Filler with Lidocaine can be combined with other Korean or international HA fillers, neuromodulators (botulinum toxin), or biostimulators (PLLA, calcium hydroxylapatite) within a single session. Always wait the recommended interval between different injectable products and confirm biocompatibility per each manufacturer’s IFU.

Both StarFill and E.P.T.Q. are manufactured by JETEMA Co. Ltd. using the same ZEEP (Zero Endotoxin and BDDE Entire Process) technology platform. They differ in branding positioning and viscosity grade specifications. E.P.T.Q. is JETEMA’s premium 3-variant range (S100/S300/S500) covering the full superficial-to-subcutaneous spectrum. StarFill is positioned as a single mid-density product at 24 mg/mL — offering JETEMA’s ZEEP purification benefits in a simplified single-SKU format suited to practices that prefer fewer SKU complexity.